Trend in prevalence of neural tube defects in Quebec

被引:69
作者
De Wals, P
Rusen, ID
Lee, NS
Morin, P
Niyonsenga, T
机构
[1] Univ Laval, Dept Med Sociale & Prevent, Ste Foy, PQ G1K 7P4, Canada
[2] Inst Natl Sante Publ, Quebec City, PQ, Canada
[3] Hlth Canada, Div Hlth Surveillance & Epidemiol, Ottawa, ON K1A 0L2, Canada
[4] Hlth Canada, Bur Nutrit Sci, Ottawa, ON K1A 0L2, Canada
[5] CLSC Reg Sherbrookoise, Sherbrooke, PQ, Canada
[6] Univ Sherbrooke, Ctr Hosp, Ctr Rech Clin, Sherbrooke, PQ, Canada
关键词
neural tube defects; folic acid; vitamin supplementation; food fortification;
D O I
10.1002/bdra.10124
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: In Canada, the first recommendations on the use of folic acid (FA) supplements by women planning a pregnancy or capable of becoming pregnant were issued in 1993. In 1998, fortification of flour with FA became mandatory. The objective of this study was to assess the impact of these measures on the prevalence of neural tube defects (NTDs) in the province of Quebec. METHODS: The study population included stillbirths, live births, and elective terminations for fetal malformations that were reported in 1992-2000 for women residing in the province of Quebec. NTD cases were identified from stillbirth certificates and hospital discharge summaries. RESULTS: There was a marked decrease in the total NTD rate after 1997. The average NTD rate was 1.89 per 1000 total births during the period of 1992-1997, and 1.28 per 1000 in 1998-2000, a 32% reduction (p < 0.001). CONCLUSIONS: Fortification of flour, which began in early 1997 and gradually became widespread, is a very plausible explanation for the timing, shape, and magnitude of the decrease in NTD prevalence observed in Quebec and other Canadian provinces. An increase in FA supplement use may have played only a minor role. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:919 / 923
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 1996, FED REGISTER, V61, P8781
[2]   Prevention of neural-tube defects with folic acid in China [J].
Berry, RJ ;
Li, Z ;
Erickson, JD ;
Li, S ;
Moore, CA ;
Wang, H ;
Mulinare, J ;
Zhao, P ;
Wong, LYC ;
Gindler, J ;
Hong, SX ;
Correa, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1485-1490
[3]  
BERTRAND L, 1990, RAPPORT ENQUETE QUEB
[4]   Neural-tube defects [J].
Botto, LD ;
Moore, CA ;
Khoury, MJ ;
Erickson, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1509-1519
[5]   Estimates of the effects of folic-acid fortification and folic-acid bioavailability for women [J].
Boushey, CJ ;
Edmonds, JW ;
Welshimer, KJ .
NUTRITION, 2001, 17 (10) :873-879
[6]   Folic acid: Is self reported use of supplements accurate? [J].
Burton, A ;
Wilson, S ;
Gillies, AJ .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2001, 55 (11) :841-842
[7]  
CRANE JMG, 2001, J SOC OBSTET GYNAECO, V23, P510
[8]   Minimum effective dose of folic acid for food fortification to prevent neural-tube defects [J].
Daly, S ;
Mills, JL ;
Molloy, AM ;
Conley, M ;
Lee, YJ ;
Kirke, PN ;
Weir, DG ;
Scott, JM .
LANCET, 1997, 350 (9092) :1666-1669
[9]   LONG-TERM OUTCOME IN SURGICALLY TREATED SPINA-BIFIDA CYSTICA [J].
DATE, I ;
YAGYU, Y ;
ASARI, S ;
OHMOTO, T .
SURGICAL NEUROLOGY, 1993, 40 (06) :471-475
[10]   Prevalence of neural tube defects in the Province of Quebec, 1992 [J].
De Wals, P ;
Trochet, C ;
Pinsonneault, L .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1999, 90 (04) :237-239